June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ahmed Alanazi: ASCO25 Plenary Session on ATOMIC Trial Results in Stage III Colon Cancer
Jun 3, 2025, 11:55

Ahmed Alanazi: ASCO25 Plenary Session on ATOMIC Trial Results in Stage III Colon Cancer

Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X:

“ASCO25 Plenary Session ATOMIC phase3 multi-center randomized open label clinical trial of adjuvant ATEZO+mFOLFOX vs mFOLFOX in resected stage III dMMR/MSI-H R0 colon cancer patients
– 3-years DFS 86.4% vs 76.6% HR 0.50
– OS data still immature
– Grade 3/4 weren’t siginficant betwen the two group
– most common irAE no new concerns  
– Neutropenia was increased among atezo group.”

ASCO25

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

ASCO